The US patent law is about to undergo a major change with a raft of reforms set to be implemented. These changes are considered to be the most comprehensive since Congress passed the 1952 patent Act. But, the path has not been smooth, with voices of dissent materializing as the government carves out its plans.
MIP and Oblon, Spivak, McClelland, Maier & Neustadt jointly hosted a roundtable discussion – at a real roundtable – in Washington DC in late summer, to discuss some of those concerns and what really needs to be done
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia